Clinical efficacy of dapagliflozin in the treatment of patients with diabetic nephropathy and its effect on albuminuria level | Synapse
September 24, 2025
Clinical efficacy of dapagliflozin in the treatment of patients with diabetic nephropathy and its effect on albuminuria level
Key Points
Dapagliflozin significantly reduces albuminuria levels in patients with diabetic nephropathy.
The study observed a notable improvement in kidney function among participants treated with dapagliflozin.
This research utilized a prospective observational study design to assess the intervention's efficacy.
The findings highlight the importance of managing albuminuria as part of diabetic nephropathy treatment.
Abstract
This prospective observational study aimed to analyze the clinical efficacy of dapagliflozin in the treatment of diabetic nephropathy and its impact on albuminuria levels.